JAK Inhibitors in Rheumatoid Arthritis
JAK inhibitors (JAKi) are targeted, small-molecule, disease-modifying therapies that are the newest class of treatments to emerge for the management of rheumatoid arthritis (RA) and the first oral disease-modifying anti-rheumatic drugs (DMARD) to demonstrate comparable clinical efficacy to biologic...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Medical Journal
2022-08-01
|
| Series: | European Medical Journal Allergy & Immunology |
| Online Access: | https://www.emjreviews.com/allergy-immunology/article/jak-inhibitors-in-rheumatoid-arthritis-j01121/ |